INBS · Intelligent Bio Solutions Inc. · Short Interest
Substantial doubt about the company's ability to continue as a going concern.
“Management believes there is a material risk that the Company's cash and cash equivalents as of June 30, 2026, of approximately $3.99 million, will be insufficient to fund its current operating plan through at least the next 12 months from the issuance of these consolidated financial statements. Accordingly, the Company will be required to raise additional funds during the next 12 months. While the Company intends to obtain additional funding through equity or debt financings, strategic collaborations, or other arrangements, there can be no assurance that such funding will be available on acceptable terms, or at all. If the Company is unable to obtain additional financing when needed, it may be required to delay, reduce, or curtail the scope of its operations and development activities. In addition, the Company may be unable to realize its assets and discharge its liabilities in the normal course of business. Accordingly, these conditions raise substantial doubt about the Company's ability to continue as a going concern, unless it can successfully meet the stated objectives and/or raise additional capital.”View the 10-K filed Aug 19, 2026
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
INBS Latest Reported Short Interest
FINRA reported 119,549 INBS shares sold short as of the September 15, 2026 settlement date, an increase of 85,876 shares. Days to cover was 1.00 based on FINRA's reported average daily volume.
Official FINRA short-interest data · share counts are restated for subsequent splits of this listing
INBS Short Interest Forecast
Equibles' model estimates 61,325 shares sold short for the September 30, 2026 settlement, -48.7% versus the latest reported position, with a likely range of 26,702 to 98,680 shares. This model prediction uses FINRA data through September 30, 2026; FINRA's official release is expected October 9, 2026.
Expected Sep 30 short interest
as of Sep 30 High confidence 94% chance it fallsPositioning score 46.0 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.
Method and coverage limits
Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.
Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.
The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.
Options positioning & squeeze sensitivity
Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.
No active listed options were found.
Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.
Assessment prepared 2026-10-06 15:44 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-10-15
Scheduled
FINRA publishes Oct 26
|
— | — | — | — |
|
2026-09-30
Scheduled
FINRA publishes Oct 9
|
— | — | — | — |
| 2026-09-15 | 119,549 | 33,673 | +85,876 | 1.00 |
| 2026-08-31 | 33,673 | 105,073 | -71,400 | 1.00 |
| 2026-08-14 | 105,073 | 49,375 | +55,698 | 1.00 |
| 2026-07-31 | 49,375 | 103,339 | -53,964 | 1.00 |
| 2026-07-15 | 103,339 | 85,165 | +18,174 | 1.70 |
| 2026-06-30 | 85,165 | 106,385 | -21,220 | 2.28 |
| 2026-06-15 | 106,385 | 91,169 | +15,216 | 1.55 |
| 2026-05-29 | 91,169 | 149,005 | -57,836 | 1.00 |
| 2026-05-15 | 149,005 | 54,635 | +94,370 | 1.00 |
| 2026-04-30 | 54,635 | 27,026 | +27,609 | 1.00 |
| 2026-04-15 | 27,026 | 44,510 | -17,484 | 1.00 |
| 2026-03-31 | 44,510 | 44,416 | +94 | 1.04 |
| 2026-03-13 | 44,416 | 94,421 | -50,005 | 1.00 |
| 2026-02-27 | 94,421 | 33,513 | +60,908 | 1.00 |
| 2026-02-13 | 33,513 | 131,837 | -98,324 | 1.00 |
| 2026-01-30 | 131,837 | 369,460 | -237,623 | 1.00 |
| 2026-01-15 | 369,460 | 128,608 | +240,852 | 1.00 |
| 2025-12-31 | 128,608 | 95,134 | +33,474 | 1.00 |
| 2025-12-15 | 95,134 | 91,454 | +3,680 | 5.41 |
| 2025-11-28 | 91,454 | 94,475 | -3,021 | 7.95 |
| 2025-11-14 | 94,475 | 82,774 | +11,701 | 3.11 |
| 2025-10-31 | 82,774 | 52,680 | +30,094 | 1.44 |
| 2025-10-15 | 52,680 | 48,522 | +4,158 | 3.91 |
Full FINRA short interest reporting calendar